Alpha Tau Medical
DRTS
11.76
+0.45
+3.93%
Alpha Tau Medical
US · DRTS
#3046 by market cap
Listed 1970
11.76
+0.45
+3.93%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Rating change
H.C. Wainwright Keeps Their Buy Rating on Alpha Tau Medical Ltd (DRTS)TipRanks · 2025/12/4
-
Rating change
Piper Sandler Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $5Market Newswire · 2025/11/21
-
Rating change
Citi Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $8Market Newswire · 2025/8/13
-
Rating change
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9Market Newswire · 2026/1/13
-
Rating change
Citi Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $9Market Newswire · 2026/3/11
-
Rating change
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $12Market Newswire · 2026/2/25
-
Rating change
Citi Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Cuts Target Price to $7Market Newswire · 2025/12/10
-
Rating change
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $12Market Newswire · 2026/4/25
-
Rating change
Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15Market Newswire · 2026/6/1
-
Rating change
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $15Market Newswire · 2026/7/22
-
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $16Market Newswire · 2026/10/20
-
Rating change
Ladenburg Thalmann Initiates Alpha Tau Medical(DRTS.US) With Buy Rating, Announces Target Price $14Market Newswire · 2026/5/12
-
Rating change
Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $17Market Newswire · 2026/6/4
-
Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $30Market Newswire · 2026/9/3
-
Rating change
Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $17Market Newswire · 2026/8/11
-
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $16Market Newswire · 2026/8/11
-
Barclays Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $30Market Newswire · 2026/10/21
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)TipRanks · 2026/9/3
-
Piper Sandler Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $22Market Newswire · 2026/11/11
-
Rating change
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2026/5/12
-
Rating change
Piper Sandler Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Cuts Target Price to $5Market Newswire · 2024/11/20
-
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $16Market Newswire · 2026/9/1
-
Rating change
Citi Initiates Alpha Tau Medical(DRTS.US) With Buy Rating, Announces Target Price $8Market Newswire · 2024/11/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.
Alpha Tau Medical discussion 0 comments